Drug-eluting Balloon Catheters Market Size & Share Report, 2034

Drug-eluting Balloon Catheters Market – By Product, By Material, By End Use – Global Forecast, 2025 to 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing prevalence of peripheral and cardiovascular diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in drug-eluting balloon catheters

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing preference for minimally invasive procedures

3.2.1.4&nbsp;&nbsp;&nbsp; Rising geriatric population

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of product

3.2.2.2&nbsp;&nbsp;&nbsp; Risk of infection associated with the use of drug-eluting balloon catheters

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Gap analysis

3.9&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Coronary artery disease drug-eluting balloon catheters

5.2.1&nbsp;&nbsp;&nbsp; Paclitaxel

5.2.2&nbsp;&nbsp;&nbsp; Sirolimus

5.3&nbsp;&nbsp;&nbsp; Peripheral vascular disease drug-eluting balloon catheters

5.3.1&nbsp;&nbsp;&nbsp; Paclitaxel

5.3.2&nbsp;&nbsp;&nbsp; Sirolimus

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Material, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Polyurethane

6.3&nbsp;&nbsp;&nbsp; Nylon

6.4&nbsp;&nbsp;&nbsp; Other materials

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.4&nbsp;&nbsp;&nbsp; Catheterization laboratories

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Aachen Resonance GmbH

9.2&nbsp;&nbsp;&nbsp; B. Braun

9.3&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

9.4&nbsp;&nbsp;&nbsp; Biosensors International

9.5&nbsp;&nbsp;&nbsp; Biotronik AG

9.6&nbsp;&nbsp;&nbsp; Boston Scientific Corporation

9.7&nbsp;&nbsp;&nbsp; Eurocor GmbH

9.8&nbsp;&nbsp;&nbsp; iVascular S.L.U.

9.9&nbsp;&nbsp;&nbsp; Zhejiang Barty Medical Technology Co.Ltd

9.10&nbsp;&nbsp;&nbsp; Lepu Medical Technology(Beijing) Co. Ltd.

9.11&nbsp;&nbsp;&nbsp; MedAlliance

9.12&nbsp;&nbsp;&nbsp; Medtronic plc

&nbsp;&nbsp;&nbsp;

Drug-eluting Balloon Catheters Market

Request Discount